Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy.
Myojin Y, Kodama T, Sakamori R, Maesaka K, Matsumae T, Sawai Y, Imai Y, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T.
Myojin Y, et al. Among authors: nozaki y.
Cancers (Basel). 2022 Feb 10;14(4):883. doi: 10.3390/cancers14040883.
Cancers (Basel). 2022.
PMID: 35205631
Free PMC article.